Blis
Deal Type
Private Equity
Sector
Technology
Fund
Maven Investor Partners
Status
Realised
Maven Investor Partners exited its investment in Blis in March 2025, following its acquisition by global telecommunications company T-Mobile which values the business at $175 million. Blis is a global programmatic advertising company that doesn’t rely on personal data. As an integrated media planning and buying platform, Blis builds audiences using accurate, consented location data combined with a broad range of rich and powerful anonymised datasets, giving Blis the deepest audience understanding available.
Since Maven’s investment, the business has invested heavily in its technology platform, increased its headcount from 240 to more than 320 employees, and expanded its international footprint, particularly in the US. During the three-year partnership, Blis’s turnover also increased by 75%.
Since Maven’s investment, the business has invested heavily in its technology platform, increased its headcount from 240 to more than 320 employees, and expanded its international footprint, particularly in the US. During the three-year partnership, Blis’s turnover also increased by 75%.
The sale of Blis marks an excellent outcome for the business, its management team, and our investors. Since our co-investment with LDC, the company has grown rapidly, expanding its footprint in the lucrative US market, with offices now in New York, Chicago, Dallas, Los Angeles, Atlanta, Cincinnati and Boston. With a best-in-class platform and talented team, Blis has firmly established itself as a leader in its field, making it a highly attractive acquisition. We wish the team well as they enter their next stage of growth with T-Mobile.
Sanjay Patel, Portfolio Director at Maven
Sanjay Patel, Portfolio Director at Maven
Meet the lead executive(s)
The Maven Income and Growth VCTs announce new share Offers
Maven completes £2.7 million investment in cybersecurity provider Xentra
Spirit Health secures £2 million debt funding package from MEIF II
Door and Gate specialists secure MEIF II backing to support growth
Maven backs NunaBio through NPIF II Maven Equity Finance